IRL757

· Integrative Research Laboratories AB

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IRL757, covering 2025-03-14 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy [Phase 1, Phase 2]